JYPC(SZ:002198)2024-07-11 10:41Financial Performance - The estimated net profit attributable to shareholders for the first half of 2024 is projected to be between 4.6 million and 5.8 million yuan, representing a decrease of 68% compared to the same period last year, which was 18.2485 million yuan [3]. - The estimated net profit after deducting non-recurring gains and losses is expected to be between 0.8 million and 1.2 million yuan, reflecting a decline of 93% from the previous year's 16.7709 million yuan [3]. - The basic earnings per share is forecasted to be between 0.0091 yuan and 0.0114 yuan, down from 0.0360 yuan per share in the same period last year [3]. - The overall revenue and net profit have declined due to slightly lower-than-expected sales of the company's main products influenced by market conditions [6]. - The financial data in the earnings forecast is preliminary and has not been audited by an accounting firm [4]. - Investors are advised to exercise caution as the actual performance will be detailed in the official half-year report to be released later [7]. Market Strategy - The company is actively maintaining market share for its leading products while exploring potential exclusive varieties to boost sales [5]. - The sales volume of potential products, such as solid ginseng and deer antler pills, has seen significant growth [6].